Science and NatureTargeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosisNews7July 31, 202400 viewsProceedings of the National Academy of Sciences, Volume 121, Issue 32, August 2024. Source : National Academy of Sciences